Following the initial investment in 2019, IW Capital has led the second round of funding to support the exciting development of this fast-growing business. Over the past year, Flarin has seen expansion through sales of Flarin Joint and Muscular Pain Relief into mass multiples such as Boots, Superdrug, Sainsbury, Morrisons as well as Amazon, Ocado and other online retailers.

QVentures has invested in Béa Fertility, bringing at-home fertility treatments to the UK. Healthcare start-up Béa Fertility has raised $1m to bring a pioneering at-home fertility treatment to the UK. QVentures joins the round led by Calm/Storm VC and which includes an innovation grant from the recent Innovate UK SMART competition.

Wysdom Dental Technologies has received £200,000 from the Midlands Engine Investment Fund, East & South East Midlands Debt Finance Fund, managed by Maven Capital Partners.

The Milton Keynes-based business plans to use the funding to invest in product development and launch its latest cloud-based software for dental practices in the UK.

Scottish bio-tech company, BioCaptiva, has developed a novel next generation “liquid biopsy” technology device that could revolutionise the early diagnosis and monitoring of difficult to detect cancers.  The University of Edinburgh spin-out has raised over £1m in seed funding from Edinburgh-based business angel investment syndicate, Archangels, and Scottish Enterprise, to help develop the technology.  To prepare the company for this next stage in its development, BioCaptiva has appointed Dr Frank Armstrong FRCPE as non-executive chairman and Dr Stephen Little as a non-executive director.

Baseimmune, the early-stage UK biotech startup, is combining big data and biological expertise to predict how viruses will change and identify ‘future-proof’ antigens that will form the crucial elements of the next generation of vaccines.  In order to further the development of its platform and start pre-clinical development in the lab, Baseimmune has secured a £685,000 investment, led by European university VC fund, Creator Fund, and includes Mike Watson, ex-president of Moderna's infectious disease spin-out with the support of Vaccitech and Oxford University. Maki VC and Rockmount Seed Investments also joined the round.

A University of Nottingham spin-out which has developed a rapid test that could be a ‘game changer’ in combatting tuberculosis (TB) in livestock has secured a £2.3m investment to help bring its product to market.  The funding for PBD Biotech has come from a consortium led by fund managers Mercia and the Foresight Group, which were both investing through the Midlands Engine Investment Fund (MEIF); the University of Nottingham; the government’s Future Fund; and private investors including farmers and veterinary practices. 

Caristo Diagnostics, the medical imaging company, has completed a multi-million-pound investment round. The round was led by BGF, the UK’s most active growth economy investor, and existing investors including Oxford Sciences Innovation (OSI), Longwall Ventures and the Oxford Technology & Innovation Fund (OTIF).

The funding will be used to roll-out Caristo Diagnostic’s CaRi-Heart^®, a ground-breaking AI-based cardiovascular risk prediction technology, which has just received its CE mark accreditation and is available for use by doctors across the UK and Europe.

PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable^®, disease targets, has completed an oversubscribed £33m ($46m) Series B investment round. The round was led by BGF, the UK’s most active growth economy investor, and included new investors XtalPi Inc., Astellas Venture Management, Trend Investment Group and o2h ventures. Existing investors Parkwalk Advisors, Morningside Ventures, and Jonathan Milner also contributed.

Oxford Medical Products (OMP) has raised £1.2M in seed investment to develop a safe and affordable weight loss capsule, which uses the same mechanism of action as a gastric balloon, but can be taken at home. The funding will be used to complete pre-clinical testing, upscale and outsource manufacturing and grow the team. The funding was led by Ada Ventures with Selvedge Venture alongside several angel investors including Dr Nick Edwards, a founder of the company, and Dr Jan Hruska, co-founder of Sophos.

Biomedical startup Adapttech has raised £2 million in a new venture capital funding round. The round was supported by existing investors including the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund;  Bionova Capital (formerly Hovione Capital), as well as new investors including ACF Investors, Wealth Club and Wren Capital.

CareLineLive, the all-in-one home care management software that increases efficiency, capacity, compliance and communication of both managers and carers by digitising their work flows, has announced that it has secured a £175k grant from the UK’s innovation agency, Innovate UK.

Albion Capital has made a successful exit from its investment in three high-end care homes managed by Berkley Care Group, the boutique care home operator. The care homes with a total of 201 beds have been sold to Korian SA, the leading European care services group for elderly and fragile people, for an undisclosed sum.